What was just approved and why it matters In December 2025, the FDA approved oral semaglutide, Wegovy tablets, for chronic weight management
Oral dosing in anecdotal human reports ranges from 250 mcg to 500 mcg per day, with cycles lasting 4 to 12 weeks depending on the severity of the injury
Plant protein-based diets with taurine supplementation are recommended because of the absence of taurine in plant protein
Otherwise it's, it's better just to go
Given the heterogeneity of genetic mutations (which can take place in different positions along the DNA, thus in different genes) and the resulting increasing number of genetic mouse models that have been generated, different animal models reproduce various aspects of ASD symptomatology, with the best animal model keeping together all three types of validity criteria
Resolves quickly with proper fluid intake but requires ongoing vigilance Serious But Less Common Side Effects The MHRA highlights several serious but less common risks that patients should know about 1 : Gallbladder problems: Including gallstones Pancreatitis: Inflammation of the pancreas, which can require hospitalization Allergic reactions: Can include swelling, rash, and trouble breathing Low blood sugar: Can happen even in non-diabetic patients using GLP-1s for weight loss Hair loss: Some patients report temporary thinning of hair Warnings About Misuse Healthcare professionals are concerned about people using GLP-1 medications inappropriately just for cosmetic weight loss
